What will create value?
A defined baseline and a measurable initiative target, with recurring EBITDA and one-time cash held apart.
For private equity
Value creation you can trace, from target to validated result.
Agentic portfolio management for PE operating teams. Targets and owners live on the plan, digital assistants carry the assembly work, and no benefit is counted until finance has validated it. The same structure across every portfolio company.
The monthly review
Every value creation review asks the same four questions.
Operating teams can answer all four. The cost is the two weeks of chasing portfolio companies, reconciling spreadsheets and rebuilding the deck that it takes to get there.
Who will deliver it?
An accountable business owner and named execution tasks, not a function with a label on it.
What needs attention?
Milestones, dependencies and unresolved risks, with health computed from what is actually open.
What has finance validated?
Period results, implementation costs and the evidence behind them, reviewed before anything is claimed.
See it end to end
One target, traced all the way down.
A walkthrough of the product using an illustrative mid-market manufacturer: the value creation plan, the owners beneath it, the work plan drafted by AI, what finance validated, and how it is measured.
The operating model
Your operating need, mapped to the work underneath.
Nothing here asks the firm to change how it runs value creation. The structures are the ones an operating team already uses.
| PE operating need | What it becomes in Neurofolio |
|---|---|
| Value creation plan | Portfolios and initiatives, with baselines, targets, planned budget and horizon on the record. |
| Accountability | Business roles and delivery tasks, so every initiative has a named owner and the work beneath it has one too. |
| Operating context | Capabilities and process references, carrying the detail each company's functions actually work from. |
| Review materials | Deliverables and saved versions: baselines, benefit claims and the monthly review, drafted to the firm's own template. |
Measurement discipline
Two value measures that never merge.
The fastest way to lose a board's confidence is a number that quietly combined a recurring saving with a one-time release. The platform keeps them in separate fields, separate sections and separate lines of the review.
Annual EBITDA
Recurring improvement
Procurement and pricing initiatives roll into an annual run rate, backed by invoices, rebates and a comparable purchasing baseline, adjusted for volume, mix, freight and transition costs.
One-time cash
Working capital release
Inventory actions produce a cash release reconciled against working capital movement. Write-offs do not produce cash, and the review will not let them look as though they did.
A completed task is not a realized benefit.
Benefit claims need a preparer, a reviewer and the evidence behind them. An analyst prepares the claim, the CFO reviews it, and the sponsor uses the reviewed result rather than the claimed one.
Where the agents work
Digital assistants carry the assembly, people keep the judgment.
The structure is not what changes with agentic AI. What changes is who keeps it current between one review and the next.
Draft the plan
Generate the work plan beneath an initiative inside the firm's own structure: phases, named task owners, dependencies and review gates, ready for the operating team to challenge rather than to write.
Keep the trace current
Chase the baseline task that slipped. Flag the benefit claim that has a target but nothing attached. Surface the gate that is still pending while the work beneath it moved on.
Draft the review
Assemble the monthly portfolio value review to the firm's template, with the annual EBITDA outlook, one-time cash and implementation costs, and the decisions required already in separate sections.
Stay on the record
Every AI run is logged append-only with its inputs, outputs, tools, tokens and cost, so the firm can see exactly what the assistants did and what it cost to do it.
Across the portfolio
Same structure every company, separate walls between them.
Each company works in its own space
A portfolio company has its own teamspace with explicitly assigned members and responsibilities. Business responsibility does not grant administration access, and belonging to two teamspaces never causes implicit sharing between them.
The firm sees the approved summary
Portfolio reporting moves up through an explicit, auditable process. Company evidence stays within its agreed scope, and human approval governs what reaches an investor summary.
Deployment principles. Authorization, retrieval boundaries and sharing rules are verified per engagement before production use of automatic memory capture or cross-company aggregation.
How to start
One portfolio company. Four weeks.
A focused setup and review cycle with the operating partner, the CEO, the CFO, the program manager and the functional leads, ending in a joint decision about whether to expand.
| Stage | Work with the operating team | Reviewable result |
|---|---|---|
| Week 1 | Agree objectives, access and finance definitions. | Company baseline and named owners. |
| Week 2 | Populate inputs and validate the proposed actions. | Reviewed initiative plans. |
| Week 3 | Run the delivery review and collect period evidence. | Task updates and an evidence-backed draft claim. |
| Week 4 | Hold the portfolio value review. | Decisions, open gaps and an expansion recommendation. |
Pilot acceptance
Take any single target and trace it to its owner, the execution work beneath it, the source evidence, and the finance review that signed it off. If that trace holds across every initiative, the pilot has done its job.
A proposed engagement structure rather than a committed delivery timetable, and not a promise of benefit realization within four weeks. Expansion depends on agreed pilot outcomes and verified production controls.
Talk to us about a portfolio pilot.
If you run value creation at a fund, sit on an operating team, or advise the people who do, we would be glad to walk you through it and compare notes on how you handle it today.
hello@neurofolio.aiCabinet Manufacturer A is an illustrative company used for demonstration. All figures on this page and in the walkthrough are planning assumptions, not realized results, and no customer evidence or approved benefit claim is represented.